Skip to menu Skip to content Skip to footer

2021

Journal Article

Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome

Majeed, Kamran, Bellinge, Jamie W., Butcher, Steele C., Alcock, Richard, Spiro, Jon, Playford, David, Hillis, Graham S., Newby, David E., Mori, Trevor A., Francis, Roslyn and Schultz, Carl J. (2021). Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome. Atherosclerosis, 319, 142-148. doi: 10.1016/j.atherosclerosis.2020.12.010

Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome

2020

Journal Article

Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study

Hofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., Wong, L. M., Taubman, K., Lee, S. T., Hsiao, E., Roach, P., Nottage, M., Kirkwood, I., Hayne, D., Link, E., Marusic, P., Matera, A., Herschtal, A., Iravani, A., Hicks, R. J., Williams, S., Murphy, D. G. and Taneja, Samir S. (2020). Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study. Journal of Urology, 204 (4), 878-879. doi: 10.1097/JU.0000000000001220.01

Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study

2020

Journal Article

Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software

Bellinge, Jamie W., Majeed, Kamran, Carr, Stuart S., Jones, Judson, Hong, Inki, Francis, Roslyn J. and Schultz, Carl J. (2020). Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software. Journal of Nuclear Cardiology, 27 (3), 952-961. doi: 10.1007/s12350-018-01587-7

Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software

2020

Journal Article

3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trial

Emmett, Louise, Tang, Reuben, Nandurkar, Rohan H., Hruby, George, Roach, Paul J., Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Ho, Bao, Chan, Lyn, van Leeuwen, Pim, Scheltema, Matthijs, Nguyen, Andrew, Yin, Charlotte, Scott, Andrew, Tang, Colin, McCarthy, Michael, Fullard, Karen, Roberts, Matthew, Francis, Roslyn and Stricker, Phillip (2020). 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trial. The Journal of Nuclear Medicine, 61 (6), 866-872. doi: 10.2967/jnumed.119.235028

3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trial

2020

Journal Article

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Hofman, Michael S., Lawrentschuk, Nathan, Francis, Roslyn J., Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Link, Emma, Marusic, Petra, Matera, Anetta, Herschtal, Alan, Iravani, Amir, Hicks, Rodney J., Williams, Scott and Murphy, Declan G. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet, 395 (10231), 1208-1216. doi: 10.1016/S0140-6736(20)30314-7

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

2020

Journal Article

Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy

Wallace, Michael C., Sek, Kenny, Francis, Roslyn J., Samuelson, Shaun, Ferguson, John, Tibballs, Jonathan, Asad, Ali, Preen, David B., MacQuillan, Gerry, Garas, George, Adams, Leon A. and Jeffrey, Gary P. (2020). Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy. Digestive Diseases and Sciences, 65 (2), 647-657. doi: 10.1007/s10620-019-05781-6

Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy

2019

Journal Article

TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876

TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

2019

Journal Article

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

Segard, Tatiana, Morandeau, Laurence M. J. A., Dunne, Marina L., Robinson, James O., Murray, Ronan J., Geelhoed, Elizabeth A. and Francis, Roslyn J. (2019). Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging. Internal Medicine Journal, 49 (8), 1016-1022. doi: 10.1111/imj.14231

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

2019

Journal Article

Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group

Armato, Samuel G., Francis, Roslyn J., Katz, Sharyn I., Ak, Guntulu, Opitz, Isabelle, Gudmundsson, Eyjolfur, Blyth, Kevin G. and Gupta, Ashish (2019). Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 130, 108-114. doi: 10.1016/j.lungcan.2018.11.033

Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group

2018

Journal Article

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification

Bellinge, Jamie W., Francis, Roslyn J., Majeed, Kamran, Watts, Gerald F. and Schultz, Carl J. (2018). In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. Journal of Nuclear Cardiology, 25 (5), 1774-1783. doi: 10.1007/s12350-018-1360-2

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification

2018

Journal Article

68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting

Segard, Tatiana, Morandeau, Laurence M. J. A., Geelhoed, Elizabeth A and Francis, Roslyn J (2018). 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting. Journal of Medical Imaging and Radiation Oncology, 62 (1), 57-63. doi: 10.1111/1754-9485.12638

68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting

2018

Journal Article

The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study

Roach, Paul J., Francis, Roslyn, Emmett, Louise, Hsiao, Edward, Kneebone, Andrew, Hruby, George, Eade, Thomas, Nguyen, Quoc A., Thompson, Benjamin D., Cusick, Thomas, McCarthy, Michael, Tang, Colin, Ho, Bao, Stricker, Philip D. and Scott, Andrew M. (2018). The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study . Journal of Nuclear Medicine, 59 (1), 82-88. doi: 10.2967/jnumed.117.197160

The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study

2017

Journal Article

Is FCH PET able to identify foci of infection superiorly to FDG PET?

Hardy, Liesel Elisabeth, Hessamodini, Hannah, Wallace, Michael and Francis, Roslyn (2017). Is FCH PET able to identify foci of infection superiorly to FDG PET?. BMJ Case Reports, 2017 bcr-2017-219944, 1-1. doi: 10.1136/bcr-2017-219944

Is FCH PET able to identify foci of infection superiorly to FDG PET?

2016

Journal Article

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

Tan, Hendrick, Joseph, David, Loh, Nelson K., McCarthy, Michael, Leong, Eugene, Siew, Teck, Segard, Tatiana, Morandeau, Laurence, Trevenen, Michelle and Francis, Roslyn J. (2016). A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. Journal of Medical Imaging and Radiation Oncology, 60 (3), 374-381. doi: 10.1111/1754-9485.12455

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

2015

Journal Article

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

Nowak, A. K., Cook, A. M., McDonnell, A. M., Millward, M. J., Creaney, J., Francis, R. J., Hasani, A., Segal, A., Musk, A. W., Turlach, B. A., McCoy, M. J., Robinson, B. W.S. and Lake, R. A. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology, 26 (12), 2483-2490. doi: 10.1093/annonc/mdv387

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

2015

Journal Article

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

Francis, Roslyn J., Segard, Tatiana, Morandeau, Laurence, Lee, Y.C. Gary, Millward, Michael J., Segal, Amanda and Nowak, Anna K. (2015). Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung Cancer, 90 (1), 55-60. doi: 10.1016/j.lungcan.2015.07.015

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

2015

Journal Article

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

Willowson, Kathy P., Tapner, Michael, The QUEST Investigator Team, , Bailey, Dale L., Willowson, K. P., Tapner, M. J., Ahmadzadehfar, H., Amthauer, H., Großer, O. S., Arbizu, J., Martí-Climent, J. M., Rodriguez-Fraile, M., Attarwala, A. A., Glatting, G., Molina-Duran, F., Bagni, O., Filippi, L., Benard, F., Celler, A., Bonutti, F., Botta, F., Ferrari, M., Boucek, J. A., Francis, R., Bourgeois, A. C., Bradley, Y. C., Pasciak, A. S., Buchholz, H. G., Miederer, M. ... Yu, N. (2015). A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study. European Journal of Nuclear Medicine and Molecular Imaging, 42 (8), 1202-1222. doi: 10.1007/s00259-015-3059-9

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

2014

Journal Article

A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver

Kao, Yung Hsiang, Luddington, Oliver S., Culleton, Simone R., Francis, Roslyn J. and Boucek, Jan A. (2014). A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver. Journal of Nuclear Medicine Technology, 42 (4), 265-268. doi: 10.2967/jnmt.114.145292

A Gelatin liver phantom of suspended 90Y resin microspheres to simulate the physiologic microsphere biodistribution of a postradioembolization liver

2014

Journal Article

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

Armato III, Samuel G., Nowak, Anna K., Francis, Roslyn J., Kocherginsky, Masha and Byrne, Michael J. (2014). Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions. Journal of Thoracic Oncology, 9 (8), 1187-1194. doi: 10.1097/JTO.0000000000000211

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

2014

Journal Article

Interventional therapies for malignant pleural effusions: The present and the future

Thomas, Rajesh, Francis, Roslyn, Davies, Helen E. and Gary Lee, Y. C. (2014). Interventional therapies for malignant pleural effusions: The present and the future. Respirology, 19 (6), 809-822. doi: 10.1111/resp.12328

Interventional therapies for malignant pleural effusions: The present and the future